Common Stock, Shares, Outstanding of Lantern Pharma Inc. from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Lantern Pharma Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • Lantern Pharma Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 11,040,219, a 2.4% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Lantern Pharma Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 11,040,219 +255,494 +2.4% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 10,784,725 +25,920 +0.24% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 10,784,725 +25,920 +0.24% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 10,784,725 +63,533 +0.59% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 10,784,725 -84,315 -0.78% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 10,758,805 -110,235 -1% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 10,758,805 -98,235 -0.9% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 10,721,192 -135,848 -1.3% 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 10,869,040 +12,000 +0.11% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 10,869,040 +38,093 +0.35% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 10,857,040 +26,093 +0.24% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 10,857,040 -231,795 -2.1% 31 Dec 2022 10-K 18 Mar 2024 2023 FY
Q3 2022 10,857,040 -329,959 -2.9% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 10,830,947 -353,092 -3.2% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 10,830,947 -350,500 -3.1% 31 Mar 2022 10-Q 03 May 2022 2022 Q1
Q4 2021 11,088,835 +4,867,908 +78% 31 Dec 2021 10-K 20 Mar 2023 2022 FY
Q3 2021 11,186,999 +4,969,422 +80% 30 Sep 2021 10-Q 01 Nov 2021 2021 Q3
Q2 2021 11,184,039 +4,966,462 +80% 30 Jun 2021 10-Q 29 Jul 2021 2021 Q2
Q1 2021 11,181,447 31 Mar 2021 10-Q 03 May 2021 2021 Q1
Q4 2020 6,220,927 +4,242,658 +214% 31 Dec 2020 10-K 10 Mar 2022 2021 FY
Q3 2020 6,217,577 30 Sep 2020 10-Q 29 Oct 2020 2020 Q3
Q2 2020 6,217,577 30 Jun 2020 10-Q 30 Jul 2020 2020 Q2
Q4 2019 1,978,269 31 Dec 2019 10-K 10 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.